Last reviewed · How we verify
Colforsin Dapropate (colforsin daropate)
Colforsin Dapropate (generic name: colforsin daropate) is a drug. It is currently in unknown development.
Colforsin Dapropate works by activating adenylate cyclase type 1, which increases the production of cyclic AMP (cAMP) within cells.
Colforsin Dapropate, also known as colforsin daropate, is a small molecule modality targeting adenylate cyclase type 1. Its exact drug class is unknown, and it has not been approved by the FDA. The current owner of Colforsin Dapropate is not specified. It is used to treat certain conditions, but specific indications are not provided. The commercial status, half-life, bioavailability, and generic manufacturers of Colforsin Dapropate are also unknown.
At a glance
| Generic name | colforsin daropate |
|---|---|
| Target | Adenylate cyclase type 1, Adenylate cyclase type 8, Solute carrier family 2, facilitated glucose transporter member 1 |
| Therapeutic area | Other |
| Phase | unknown |
Mechanism of action
Think of cAMP as a messenger that helps cells respond to signals. When adenylate cyclase type 1 is activated, it produces more cAMP, which can help cells do their job more efficiently. This can lead to various effects depending on the cell type and the condition being treated.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Colforsin Dapropate CI brief — competitive landscape report
- Colforsin Dapropate updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Colforsin Dapropate
What is Colforsin Dapropate?
How does Colforsin Dapropate work?
What is the generic name of Colforsin Dapropate?
What development phase is Colforsin Dapropate in?
What does Colforsin Dapropate target?
Related
- Target: All drugs targeting Adenylate cyclase type 1, Adenylate cyclase type 8, Solute carrier family 2, facilitated glucose transporter member 1
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing